´╗┐ Vectura Group Plc VEC, Financial Strategic: Ken Research
Vectura Group Plc (VEC) - Financial and Strategic SWOT Analysis Review

Vectura Group Plc (VEC) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH7949FSA
  • |
  • Pages: 52
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Vectura Group Plc (VEC) Financial and Strategic SWOT Analysis Review provides you an in depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi annual financial statements published by the company for 5 interims history.

Highlights

Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform. It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, pulmonary fibrosis and other diseases. The company develops products based on a wide range of proprietary lung delivery technologies, including device and formulation capabilities. Vectura has a varied portfolio of drugs in clinical development, comprising several novel and generic programs that are partnered with several global biotechnology and pharmaceutical companies. Vectura is headquartered in Chippenham, Wiltshire, the UK.

Vectura Group Plc Key Recent Developments

Jun 01,2018: Vectura Group Appoints Anne Whitaker As Non Executive Director

Apr 20,2018: Vectura Announces Senior Management Change

Apr 20,2018: Vectura Group: Directorate Change Chief Financial Officer

Mar 21,2018: Vectura Group: 2017 Preliminary Results

Mar 21,2018: Vectura Group: 2017 Preliminary Results Performance in line with expectations, with strong in market growth from key inhaled products

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 About the Company 6

Vectura Group Plc Key Facts 6

Vectura Group Plc Key Employees 7

Vectura Group Plc Key Employee Biographies 8

Vectura Group Plc Major Products and Services 9

Vectura Group Plc History 11

Vectura Group Plc Company Statement 14

Vectura Group Plc Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Section 2 Company Analysis 17

Company Overview 17

Vectura Group Plc Business Description 18

Vectura Group Plc Corporate Strategy 19

Vectura Group Plc SWOT Analysis 20

SWOT Analysis Overview 20

Vectura Group Plc Strengths 20

Vectura Group Plc Weaknesses 21

Vectura Group Plc Opportunities 22

Vectura Group Plc Threats 23

Vectura Group Plc Key Competitors 24

Section 3 Company Financial Ratios 25

Financial Ratios Capital Market Ratios 25

Financial Ratios Annual Ratios 26

Performance Chart 29

Financial Performance 29

Financial Ratios Interim Ratios 30

Financial Ratios Ratio Charts 31

Section 4 Company's Lifesciences Financial Deals and Alliances 32

Vectura Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

Vectura Group Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 33

Vectura Group Plc, Recent Deals Summary 34

Section 5 Company's Recent Developments 35

Apr 20, 2018: Vectura Group: Directorate Change Chief Financial Officer 35

Mar 21, 2018: Vectura Group: 2017 Preliminary Results 36

Mar 21, 2018: Vectura Group: 2017 Preliminary Results Performance in line with expectations, with strong in market growth from key inhaled products 37

Nov 29, 2017: Vectura Group appoints Juliet Thompson to its Board of Directors 39

Oct 24, 2017: Vectura Group: Ultibro Breezhaler continues to deliver strong underlying growth in Q3 40

Sep 06, 2017: Vectura Group: 2017 Interim Results 41

Mar 21, 2017: Vectura Group: Preliminary Results for the nine month period ended 31 December 2016 43

Mar 21, 2017: Vectura Group Announces Preliminary Results for the nine month period ended 31 December 2016 45

Mar 06, 2017: Vectura Group: Board Change 46

Feb 16, 2017: Vectura achieves GBP9 million royalty cap from GSK Ellipta« products 47

Section 6 Appendix 48

Methodology 48

Ratio Definitions 48

About GlobalData 52

Contact Us 52

Disclaimer 52

List of Figures

Vectura Group Plc, Performance Chart (2013 2017) 29

Vectura Group Plc, Ratio Charts 31

Vectura Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

Vectura Group Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 33

List of Tables

Vectura Group Plc, Key Facts 6

Vectura Group Plc, Key Employees 7

Vectura Group Plc, Key Employee Biographies 8

Vectura Group Plc, Major Products and Services 9

Vectura Group Plc, History 11

Vectura Group Plc, Subsidiaries 16

Vectura Group Plc, Key Competitors 24

Vectura Group Plc, Ratios based on current share price 25

Vectura Group Plc, Annual Ratios 26

Vectura Group Plc, Annual Ratios (Cont...1) 27

Vectura Group Plc, Annual Ratios (Cont...2) 28

Vectura Group Plc, Interim Ratios 30

Vectura Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 32

Vectura Group Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 33

Vectura Group Plc, Recent Deals Summary 34

Currency Codes 48

Capital Market Ratios 48

Equity Ratios 49

Profitability Ratios 49

Cost Ratios 50

Liquidity Ratios 50

Leverage Ratios 51

Efficiency Ratios 51

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Vernalis Plc

Novartis AG

GlaxoSmithKline Plc

Consort Medical plc

AstraZeneca Plc

Vectura Group Plc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 8431
Site License
USD 250 INR 16863
Corporate User License
USD 375 INR 25294

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com